<< All Speakers

Marc Foidart

CEO, B2H / Bridge 2 Health

Marc obtained a Master in Business Engineering from the University of Liège (1998). He is co-founder of EKLO ASBL, Member of the Executive Committee of Noshaq SA in charge of the Life Sciences sector, CEO of B2H SA, the public company superseeding the Liege life sciences ecosystem, and CEO of Epimede SA, a 50M€ Belgian based private high-tech growth fund.

He has more than 15 years’ of experience in strategic consulting and investment at all stages of development of small and medium high tech- high growth life sciences enterprises. He played a key role in several financing rounds at critical development stages of various Belgian young biotech companies among which : Mithra Pharmaceuticals SA, Imcyse SA, Uteron Pharma SA, PDC Line Pharma SA, Diagenode SA.

As an entrepreneur, Marc Foidart is Co-Founder and past CEO of Arlenda SA, a spin-off company of the University of Liège providing expert statistical solutions to the pharmaceutical, chemical and environment industries. He is also Co-Founder and Executive Chairman of Eyed Pharma SA, a start-up company developing innovative controlled release micro-implants in ophthalmology.

Marc Foidart has been associate professor at the University of Liege since 2011.

Marc Foidart has held the following main mandates over the past ten (10) years:

Main Past Mandates: Arlenda SA, Gambit Financial Solutions SA, Uteron Pharma SA, Mithra Pharmaceuticals SA , Samtech CA (Siemens Group), Spacebel SA, Amos SA

Main Current Mandates: Imcyse SA, Eyed Pharma SA (Excutive Chairman), Bridge to Health SA, Noshaq Spin-off SA, Diagenode SA, Gesval SA, Accessia GMP SA, Magnisense SARL, Dendrogenix SA


Session:

KEYNOTE _ Life Sciences as a corner stone for territorial economic development : the case of the Liège B2H ecosystem

Location Einstein ABC Room Start / end time 9:10 am to 9:30 am

Life Sciences are a booming economic sector in Europe, Belgium and Wallonia. After having quantified the impact of this sector on the Belgian and Walloon economy, the presentation shows how the Liege community is leveraging on a critical mass of « intellectual assets » and a long term favorable Walloon Government’s strategy to design a comprehensive solution that really fosters the development of a Life Science Economic Hub, composed of a mix of endogeneous start-ups and academic spin-offs and of foreign companies relocating themselves in the ecosystem, attracted by the offer put in place. A benchmark of the Liege area with its best in class neighbouring regions will also highlight critical success factors and key actions to be taken to allow the ecosystem to reach the next level and significantly contribute to the economic turnaround of the region.